| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice. | Hepatology | 2009 | 1.09 |
| 2 | Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease. | Clin Chim Acta | 2007 | 0.94 |
| 3 | Glycosphingolipids and insulin resistance. | Adv Exp Med Biol | 2011 | 0.84 |
| 4 | CCL18: a urinary marker of Gaucher cell burden in Gaucher patients. | J Inherit Metab Dis | 2006 | 0.83 |